References

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954870/

https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.042622

https://www.ahajournals.org/doi/10.1161/CIR.0000000000001193

https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.063988#:~:text=Pulsed%20field%20ablation%20was%20shown,paroxysmal%20and%20persistent%20AF%20cohorts.

https://www.ahajournals.org/doi/10.1161/CIRCEP.120.009288

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358279/

Huzar's basic dysrhythmias and acute coronary syndromes: interpretation and management. Wesley, 2011

https://www.ncbi.nlm.nih.gov/books/NBK526072/

Medtronic academy

Microport academy

Device manuals across all companies

Information provided by device companies

MINERVA trial

NOAH-AFNET 6 trial

ASSERT trial - 2012 & 2017 papers

Parsons et al., 2017. The CHA2DS2-VASc Score A Predictor of Thromboembolic Events and Mortality In Patients With an Implantable Monitoring Device Without Atrial Fibrillation. Mayo Clin Proc. 92(3): 360–369

ZHu et al., 2015. The HAS‐BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta‐analysis. Clinical Cardiol. 38, 9, 555–561